ПОЛУЧЕНИЕ ПРЕПАРАТОВ СПЕЦИФИЧЕСКИХ АНТИГЕНОВ И СЫВОРОТОК ПРОТИВ ВИРУСА БОЛЕЗНИ МАРЕКА И ИХ ИСПОЛЬЗОВАНИЕ В ИММУНОФЕРМЕНТНОМ АНАЛИЗЕ
Abstract
by PSR, SDS-PAGE and Western immunoblot analysis. Specific sera against 3 MDV subtypes were
obtained. Using of the antigens and sera in indirect ELISA for research of humoral antibodies was analyzed.
About the Authors
М. ВолковаRussian Federation
Г. Батченко
Russian Federation
М. Шульпин
Russian Federation
Н. Мудрак
Russian Federation
Л. Щербакова
Russian Federation
В. Дрыгин
Russian Federation
Ш. Куляшбекова
Russian Federation
References
1. Шульпин, М.И. Выявление вируса болезни Марека трёх серотипов с помощью мультиплексной полимеразной цепной реакции/М.И. Шульпин, Е.Н. Чернышова, И.А. Чвала, В.П. Мельников и др.// 1-й Междунар. вет. конгр. по птицеводству. М., 2005. С.161-163.
2. Ярыгина, Е.И. Получение антигенов вируса болезни Марека, различающихся по перекрёстной серотипической активности/Е.И. Ярыгина, В.А. Лукина, Б.В. Соловьёв и др.//Вестник Российской академии с/х наук. 2001. №5. С.67-70.
3. Ярыгина, Е.И. Разнообразие поликлональных антител к серотипам вируса болезни Марека один из критериев поствакцинального ответа/ Е.И. Ярыгина// Доклады Российской Академии с/х наук. 2005. №5. С. 57-59.
4. Barrow, D.A. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus/A.D. Barrow, S.C. Burgess, S.J. Baigent at all.// Journal of General Virology. 2003. V.84. P.2635-2645.
5. Calnek, B.W. Pathogenesis of Marek's disease virus infection. Current Topiks in Microbiology and Immunology. 2001. V.255. P.25-55.
6. Chen, X. Identification of a unique Marek's disease virus gene wich encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells/X. Chen, P.J.A. Sondermeijer, L.F. Velicer// Journal of Virology. 1992. V.66. P.85-94.
7. Gimeno, I.M. The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV/ I.M. Gimeno, R.L. Witter, H.D. Hunt at all// Journal of Virology. 2005. V.79. P. 4545-4549.
8. Lee, L.F. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine/ L.F. Lee, R.L. Witter// Avian diseases. 1991. V.35. P.452-459.
9. Nazerian, K. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus/ K.Nazerian, L.F. Lee, N. Yanagida, R Ogava// Journal of Virology. 1992. V.66. P.1409-1413.
10. Schat, K.A. Immune responses to Marek's disease virus infection/K.A. Schat, C.J. Markowski-Grimsrud// Curr Top Microbiol. Immunol.. 2001. V.255. P. 91-120.
11. Silva, R.F. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus and turkey herpesvirus. R.F. Silva, L.F. Lee //Virology. 1984. V.136. P.307-320.
12. Tischer, B.K. DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens/ B.K. Tischer, D. Schumacher, M. Beer at al.//Journal of General Virology. 2002. V.22. P.2367-2376.
13. Tischer, B.K.High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro/ B.K. Tischer, D. Schumacher, D. Chabanne-Vautherot at all.// Journal of Virology. 2005. V. 79. P.5889-5899.
14. Zelnik, V. An Enzyme-linked immunosorbent assay (ELISA) for detection of Marek's disease virusspecific antibodies and its application in an experimental vaccine trial/ V.Zelnik, O. Harlin, F.Fehler at al.//Journal of Veterinary Medicine Series B. 2004. V.51. P.61-67.
Review
For citations:
, , , , , , . Russian Journal of Veterinary Pathology. 2008;(2):25-32. (In Russ.)